0001735276-20-000105.txt : 20201130 0001735276-20-000105.hdr.sgml : 20201130 20201130160323 ACCESSION NUMBER: 0001735276-20-000105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201125 FILED AS OF DATE: 20201130 DATE AS OF CHANGE: 20201130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHARP PHILLIP A CENTRAL INDEX KEY: 0001226295 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36407 FILM NUMBER: 201358180 MAIL ADDRESS: STREET 1: BIOGEN INC LEGAL DEPARTMENT STREET 2: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER NAME: FORMER CONFORMED NAME: SHARP PHILIP A DATE OF NAME CHANGE: 20030407 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770602661 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 WEST KENDALL STREET STREET 2: HENRI A. TERMEER SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 551-8200 MAIL ADDRESS: STREET 1: 675 WEST KENDALL STREET STREET 2: HENRI A. TERMEER SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020724 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-11-25 0 0001178670 ALNYLAM PHARMACEUTICALS, INC. ALNY 0001226295 SHARP PHILLIP A 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2020-11-25 4 M 0 30000 9.3 A 265633 D Common Stock 2020-11-25 4 S 0 11523 124.3 D 254110 D Common Stock 2020-11-25 4 S 0 15715 125.05 D 238395 D Common Stock 2020-11-25 4 S 0 2117 126.16 D 236278 D Common Stock 2020-11-25 4 S 0 645 127.44 D 235633 D Common Stock 31266 I by Trust Stock Option (right to buy) 9.3 2020-11-25 4 M 0 30000 0.0 D 2012-06-09 2021-06-09 Common Stock 30000 0 D The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. The 30,000 options exercised and sold by the reporting person were due to expire on June 9, 2021. Sale prices ranged from $123.65 to $124.64. Sale prices ranged from $124.66 to $125.60. Sale prices ranged from $125.72 to $126.60. Sale prices ranged from $127.23 to $127.92. Includes shares of ALNY common stock held in trusts for the benefit of the children of Dr. Sharp, of which the spouse of Dr. Sharp and children are the trustees. By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Phillip A. Sharp 2020-11-30